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CASE REPORT

Case of Tuberous Sclerosis with
Pulmonary Involvement

Arzu BALKAN1
Cantürk TAﬁCI1
2

Carl R. FUHRMAN

Abstract: Tuberous sclerosis is a rare genetic disorder. The diagnosis of tuberous sclerosis requires the
presence of two major or one major and two minor features. Pulmonary involvement has been reported to
occur in less than 1% in patients and carries a poor prognosis. We present a female tuberous sclerosis patient
with pulmonary involvement, evaluated for a positive PPD reaction.
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Pulmoner Tutulumla Seyreden Tuberoskleroz Olgusu
Özet: Tuberoskleroz nadir rastlanan genetik bir hastal›kt›r. Tuberoskleroz tan›s› iki major veya bir major iki
minor bulgunun varl›¤› ile konur.
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Pulmoner tutulum % 1 den daha az hastada görülür ve kötü prognoz kriteri olarak raporlanmaktad›r.
PPD pozitifli¤i nedeniyle araﬂt›r›lan pulmoner tutulumu olan bir bayan hastay› sunmay› uygun gördük.
Anahtar Sözcükler: Tuberoskleroz, pulmoner tutulum, LAM, böbrek, radyoloji

Introduction
Tuberous sclerosis (TS) is an autosomal dominant genetic disorder with a reported
incidence of approximately 1 in 5,000-10,000 live births (1,2). Although it is a genetic
disorder, only one-third of cases are familial. The criteria for diagnosis of TS were
defined at a consensus conference in 1998. According to these criteria, diagnosis
requires the presence of two major features, or one major and two minor features
(Table 1) (3).

Table 1. Tuberous sclerosis criteria.
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Major

Minor

facial angiofibromas or forehead plaque

multiple randomly distributed pits in dental enamel

no traumatic ungula or periungual fibroma

rectal hamartomatous polyps

hypomelanotic macules (three or more)

bone cysts

shagreen patch (connective tissue nevus)

cerebral white matter radial migration lines

multiple retinal nodular hamartomas

gingival fibromas

brain cortical tuber

nonrenal hamartomas

subependymal nodules

retinal achromic patch

subependymal giant cell astrocytoma

confetti skin lesions

cardiac rhabdomyoma

multiple renal cysts

pulmonary LAM
renal AML
LAM: Lymphangioleiomyomatosis. AML: Angiomyolipoma.
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Case Report
A 57-year-old female patient was admitted to the
hospital for evaluation of a positive PPD. She had no
respiratory complaints and had never smoked.
Complete blood count, routine biochemical analysis
and urine analysis were normal. The posteroanterior
chest radiograph was reported to show a right paraspinal
mass in the lower zone (Figure 1). Computed
tomography (CT) scan of the chest was obtained. It
confirmed that the mass represented a large intrathoracic
hiatal hernia. Representative CT images of the lung
showed multiple thin-walled lung cysts (Figures 2a, 2b).

(a)

The upper abdominal CT scan showed multiple
bilateral renal masses, some of which contained fat
(Figures 3a, 3b).
The patient had a clinical history of TS with facial
angiofibromas, mental retardation and seizures for a long
period. The previous brain CT demonstrated
characteristic periventricular subependymal calcifications.
On the basis of the above findings, the diagnosis of TS
was made.

Discussion
Tuberous sclerosis (TS) is an uncommon autosomal
dominant genetic disorder. Some studies have established
(b)
Figures 2. Axial CT images of the lungs obtained at the levels of the
aortic arch (2a) and lung bases (2b) showing cystic lung
disease. The right paraspinal abnormality on the chest
radiograph is explained by a large hiatal hernia.

a direct relationship with mutations in two genes, TSC1
on chromosome 9q 34 and TSC2 on chromosome 1bp13
(4).
Tuberous sclerosis is characterized by multiple
hamartomas in one or many organs, particularly the skin
(adenoma sebaceum, angiofibromas, pigmented lesions),
central nervous system (periventricular tubers,
subependymal calcifications), retina, and kidneys
(angiomyolipomas, AML) (5). These hamartomas are
composed of varying amounts of mature adipose tissue,
smooth muscle, and blood vessels (6).

Figure 1. Chest radiograph showing a soft tissue abnormality in the
lower right paraspinal region at the right lung base.
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The classic clinical triad for TS consists of seizures,
mental retardation, and facial angiofibromas. This classic
triad occurs in fewer than 50% of patients with TS (3).

Vol: 37

No: 4

Tuberous Sclerosis with Pulmonary Involvement

(a)

August 2007

(b)

Figures 3. (a) Contrast enhanced axial CT image of the upper abdomen at the level of liver and body of pancreas. There is a cystic mass in the left
upper quadrant showing a fluid-fluid level.
(b) Contrast enhanced axial CT image of the upper abdomen obtained at the level of kidneys.

Pulmonary involvement has been reported to occur in
less than 1% of patients. The histological appearance of
pulmonary involvement in TS is identical to pulmonary
lymphangioleiomyomatosis (LAM) (5). There is diffuse
parenchymal smooth muscle infiltration, which results in
destruction of alveolar septa and formation of pulmonary
cysts. This similar histology has led to the speculation that
LAM may be a forme fruste of TS (6,7).
The onset of pulmonary involvement with TS is rare
before the fourth decade of life and occurs more
commonly in females with TS. Pulmonary TS may present
clinically with progressive dyspnea, spontaneous
pneumothorax, chest pain, and rarely hemoptysis (8).
The proliferation of smooth muscle can also involve
the lymphatics in the chest and abdomen. This can result
in lymph node enlargement and lymphatic obstruction
with resultant chylothorax or chylous ascites (9).
In cases of mild pulmonary TS, the patient may be
completely asymptomatic and the chest radiograph can
appear normal. In more severe cases, the cystic nature of
the disease may be apparent, producing a honeycomb
pattern on chest radiographs. The pulmonary cysts are
usually much easier to identify and characterize by CT
scanning. The characteristic CT appearance is cystic
airspaces of variable sizes. The walls of the cysts are
usually very thin and sharply defined (Figures 2a, 2b).
The CT appearances of TS cysts are identical to
pulmonary LAM, and are also very similar to the cystic
lung disease in Langerhans histiocytosis (LH). The cysts in
LAM and TS do not typically have the upper zone

predilection (at least in early disease) or the more bizarre
shapes that tend to occur with LH (4).
Distinction between LH cystic lung disease and the
cysts occurring in LAM and TS is often not possible based
on CT appearance alone. The chest imaging findings in
TS, when combined with clinical history and physical
findings, will usually establish the correct diagnosis
without the need for a lung biopsy. Pulmonary function
testing (PFT) is usually abnormal in cases with significant
pulmonary involvement. The most common PFT
abnormalities are impaired gas transfer and obstruction.
Pulmonary involvement can cause progressive dyspnea,
respiratory failure, cor pulmonale, and death (9). Renal
hamartomas (AML) occur in 40-80% of patients with TS
(10).
The contrast enhanced CT scan of the upper abdomen
in the present case (Figure 3b) showed multiple bilateral
renal masses, some of which contained fat. The fat
component in these renal masses is apparent on the CT
images when the low-density components of the masses
are visually compared to subcutaneous and
retroperitoneal fat. CT region of interest (ROI)
measurements confirmed the presence of fat in these
renal masses. Spontaneous hemorrhage is a common and
potentially life-threatening complication of renal AMLs
(9).
A fluid-fluid level was present in one of the large renal
AMLs arising in the upper pole of the left kidney (Figure
3a), indicating a resolving recently contained bleeding
with the characteristic CT appearance of a fluid-fluid level
related to the different CT attenuations of different blood
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products. Because of the high incidence of renal
involvement in patients with TS, it is important to
recognize and manage the bleeding complications of
AMLs. Common clinical symptoms of bleeding in AMLs
include flank pain, retroperitoneal signs, hematuria, and
symptoms similar to pyelonephritis. Most cases of renal
AMLs are detected incidentally during abdominal imaging
examinations. The CT appearance of AMLs is usually
diagnostic with single or multiple renal masses containing
fat densities, as was present in our patient. These lesions
can range in size from a few millimeters to over 10 cm
(9).
It is now recognized that some women with LAM also
have renal AMLs, but have no other TS features. Women
with LAM and only renal AMLs do not have an increased
risk of having children with TS involvement (11).
The identification of a renal AML in a woman with
LAM is insufficient for a clinical diagnosis of TS without
other diagnostic criteria of TS (7). The exact relationship
between LAM and TS remains uncertain. The renal AMLs
occurring in association with LAM are usually solitary, and
abdominal CT is currently the best imaging modality for
screening patients with LAM for the presence of renal
AMLs. Renal biopsy is usually unnecessary since the CT
appearance is almost always diagnostic (9).
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Patients with TS have a decreased survival with renal
disease and brain tumors as the most common causes of
death (12).
Small (<4 cm) asymptomatic renal AMLs usually do
not require treatment, and can be followed by serial
imaging. Intervention (selective arterial embolization or
conservative partial nephrectomy) may be considered for
larger AMLs (>4 cm) or AMLs that grow. Treatment
should be directed to preserving renal function and
avoiding nephrectomy if at all possible (12).
Pulmonary involvement in TS usually carries a poor
prognosis, with progression of lung disease being
common (13).
There is currently no effective treatment. Because of
its similarity to LAM, treatment with progesterone,
luteinizing hormone-releasing hormone (LHRH) analogs,
and/or oophorectomy have been tried in women with
progressive pulmonary TS. Lung transplantation could be
an alternative option in some patients (14).
In conclusion, this case report reviews the
characteristic imaging findings of pulmonary involvement
in TS, and shows the similarity in the radiological features
of pulmonary TS and LAM.
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